GSI 150 (Vitekta 150 mg)
Generic Name: elvitegravir
Pill imprint GSI 150 has been identified as Vitekta 150 mg.
Vitekta is used in the treatment of hiv infection and belongs to the drug class integrase strand transfer inhibitor. There is no proven risk in humans during pregnancy. Vitekta 150 mg is not a controlled substance under the Controlled Substance Act (CSA).
More about Vitekta (elvitegravir)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Interactions
- Support Group
- En Español
- 0 Reviews – Add your own review/rating
- Drug class: integrase strand transfer inhibitor
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.